Investor Relations

Press Room

Search
press release List
No Subjects Date hit
40 Yungjin signed a collaborative research agreement with Curome for treatment of rare mitochondrial disease 2021-09-13 1450
39 Abliva announces positive clinical phase 1a/b results in PMD patients for KL1333 that has been in-licensed from Yungjin 2021-05-31 970
38 Family-Friendly certification proves that Yungjin Pharm is a great place to work 2020-12-02 845
37 Yungjin PharmĄ¯s Jeonju Factory, Practicing the love of neighbors through rice donation 2020-11-27 1030
36 Yungjin Pharm Signs $11M Contract Extension to Supply Cephalosporin-based Antibiotics with Mylan Seiyaku. 2020-10-21 944
35 Yungjin Pharm signs Collaborative Research Agreement for Parkinson's Disease Treatment 2020-10-20 811
34 Yungjin Pharm and Guangzhou Tosun(China) Contracted a Supply Agreement of Cefcapene Pivoxil 2020-07-29 914
33 Yungjin Pharm donated 'Alvityl Plus D Syrup' to Holt children's services, Inc. 2020-07-22 684
32 At AACR 2020, YJP presents significant data regarding antitumor activity 2020-07-01 701
31 Yungjin Pharm's Investor Relations(IR) Conference in 2019 2019-12-29 908
Previous Page1234next page

Quick menu